Systemic lupus erythematosus (disorder)

BHSLE: Sequencing Based Genetic Analysis of Systemic Lupus Erythematosus (SLE)

Year Started: 2015

DNA and clinical information are used to look for similarities and differences between people with SLE and those unaffected by the disease. These data can be used to identify genetic differences that are more common in SLE patients and then ask how these genetic factors affect the immune system and how they influence the nature and severity of the disease. Current recruitment status for this study is 220 patients.



Access:
Closed to access
Type:
Disease specific
Status:
In progress
Consent restrictions:
Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Freezer temperature logs 0 - 3 months
Donor Ethnicity 3 - 6 months


Unknown

Data not recorded

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
DNA -60°C to -85°C N/A Affected 75% -99%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Affected 51 - 75%
Plasma -60°C to -85°C N/A Affected 75% -99%

Rheumatoid arthritis (disorder)

IRMA: Investigation of the Role of Microbiota in Arthritic Inflammation in DMARD-naïve Early Arthritis patients

Year Started: 2017

Observational, single site study. There are many reports that strongly suggest that certain bacteria living in the mouth and in the intestines of RA patients may cause and/or worsen RA. The purpose of the observational IRMA study is to identify RA patients who also have periodontitis (inflammation in their gums caused by bacteria) and compare them to healthy individuals. We will compare the presence of bacteria in the mouth with the RA disease activity and severity and investigate whether the presence of periodontitis and certain bacteria are related to the inflammation in joints and severity of RA disease. The long term goal is to determine if treating periodontitis, caused by certain bacteria, may help to improve the outcomes for patients with RA. Current recruitment status for this study is 12 patients.



Access:
Closed to access
Type:
Disease specific
Status:
In progress
Consent restrictions:
Xenograft restriction


Associated Data Type Procurement Timeframe
Clinical records 3 - 6 months
Freezer temperature logs 0 - 3 months
Pathology records 3 - 6 months
Physiological/biochemical measurements 3 - 6 months
Treatment records 3 - 6 months
Donor Ethnicity 3 - 6 months


Unknown

Data not recorded

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
DNA -60°C to -85°C N/A Affected 75% -99%
Faeces -60°C to -85°C N/A Affected 75% -99%
Peripheral blood mononuclear cells (PBMC) Liquid nitrogen liquid phase N/A Affected 75% -99%
Plasma -60°C to -85°C N/A Affected 75% -99%
RNA -60°C to -85°C N/A Affected 26 - 50%
Saliva -60°C to -85°C N/A Affected 75% -99%
Serum -60°C to -85°C N/A Affected 75% -99%
Tissue specimen Surgical procedure (procedure) RT Paraffin Affected 26 - 50%
Whole blood -60°C to -85°C N/A Affected 75% -99%